218 related articles for article (PubMed ID: 32031158)
1. Operable gastric adenocarcinoma with different histological subtypes: Cancer-specific survival in the United States.
Lin CL; Zhu GW; Huang YJ; Zheng W; Yang SG; Ye JX
Saudi J Gastroenterol; 2020; 26(1):46-52. PubMed ID: 32031158
[TBL] [Abstract][Full Text] [Related]
2. A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.
Guo Q; Wang Y; An J; Wang S; Dong X; Zhao H
Technol Cancer Res Treat; 2021; 20():15330338211027912. PubMed ID: 34190015
[TBL] [Abstract][Full Text] [Related]
3. Anatomic Subsites and Prognosis of Gastric Signet Ring Cell Carcinoma: A SEER Population-Based 1 : 1 Propensity-Matched Study.
Xie Y; Song X; Dong W; Jin H; Ni Z; Li X; Huang H
Biomed Res Int; 2022; 2022():1565207. PubMed ID: 35141330
[TBL] [Abstract][Full Text] [Related]
4. Novel nomogram to predict the overall survival of postoperative patients with gastric signet.
Liu D; Ding R; Wang L; Shi E; Li X; Zhang C; Zhang Y; Wang X
BMC Gastroenterol; 2023 Aug; 23(1):284. PubMed ID: 37587418
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Nomograms for Nonelderly Adults with Gastric Signet Ring Cell Carcinoma.
Wang H; Peng Y; Huang Q; Wu J; Zhang M
Biomed Res Int; 2021; 2021():1274527. PubMed ID: 33834061
[TBL] [Abstract][Full Text] [Related]
6. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology.
Wang Z; Zhang X; Hu J; Zeng W; Zhou Z
J Visc Surg; 2015 Dec; 152(6):357-61. PubMed ID: 26481069
[TBL] [Abstract][Full Text] [Related]
8. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
Chon HJ; Hyung WJ; Kim C; Park S; Kim JH; Park CH; Ahn JB; Kim H; Chung HC; Rha SY; Noh SH; Jeung HC
Ann Surg; 2017 May; 265(5):946-953. PubMed ID: 27232252
[TBL] [Abstract][Full Text] [Related]
9. Nomograms to Predict Overall and Cancer-Specific Survival in Gastric Signet-Ring Cell Carcinoma.
Chen CL; Xue DX; Chen HH; Liang MZ; Lin DZ; Yu M; Chen JX; Wu WL
J Surg Res; 2021 Oct; 266():13-26. PubMed ID: 33979736
[TBL] [Abstract][Full Text] [Related]
10. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma in the Stomach: Retrospective Analysis of Single Center Database.
Liu X; Cai H; Sheng W; Yu L; Long Z; Shi Y; Wang Y
PLoS One; 2015; 10(12):e0144420. PubMed ID: 26642199
[TBL] [Abstract][Full Text] [Related]
12. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a predictive model associated with lymph node metastasis of gastric signet ring carcinoma patients.
Wang W; Xia Y; He C
Medicine (Baltimore); 2023 Nov; 102(45):e36002. PubMed ID: 37960779
[TBL] [Abstract][Full Text] [Related]
14. BMI-adjusted prognosis of signet ring cell carcinoma in patients undergoing radical gastrectomy for gastric adenocarcinoma.
Wang JB; Lin MQ; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Huang CM
Asian J Surg; 2021 Jan; 44(1):116-122. PubMed ID: 32467008
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US.
Pokala SK; Zhang C; Chen Z; Gamboa AM; Cristofaro SL; Keilin SA; Cai Q; Willingham FF
J Gastrointest Surg; 2018 Apr; 22(4):569-577. PubMed ID: 29313289
[TBL] [Abstract][Full Text] [Related]
16. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
17. Influence of marital status on the survival of patients with gastric cancer.
Zhou R; Yan S; Li J
J Gastroenterol Hepatol; 2016 Apr; 31(4):768-75. PubMed ID: 26513206
[TBL] [Abstract][Full Text] [Related]
18. A novel web-based dynamic prognostic nomogram for gastric signet ring cell carcinoma: a multicenter population-based study.
Jiang Y; Hu H; Shao X; Li W; Lu Y; Liang J; Tian Y
Front Immunol; 2024; 15():1365834. PubMed ID: 38660300
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of FAR and a novel FAR-CA125 score in resectable gastric signet ring cell carcinoma patients.
Shen Y; Li Y; Wang Z; Xu W; Wang W; Chen X
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9597-9608. PubMed ID: 37222811
[TBL] [Abstract][Full Text] [Related]
20. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma.
Bamboat ZM; Tang LH; Vinuela E; Kuk D; Gonen M; Shah MA; Brennan MF; Coit DG; Strong VE
Ann Surg Oncol; 2014 May; 21(5):1678-85. PubMed ID: 24394986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
